Latest Headlines

  1. Varian Expands Cancer Care Portfolio With Noona Healthcare Acquisition

    Varian (NYSE: VAR) today announced the acquisition of privately-held software company Noona Healthcare, developer of a cloud-based, mobile service designed to capture cancer patient-reported outcomes (PROs). The Noona patient software app lets clinics capture PROs and communicate directly with patients. This acquisition expands Varian's portfolio of cancer care solutions and fits the company's long-term growth and value creation strategy.

  2. Canada Clears Medtronic’s Insulin Pump For Type 1 Diabetes

    Medtronic of Canada Ltd., a subsidiary of Medtronic plc (NYSE: MDT), today announced it has received a licence from Health Canada for the MiniMed™ 670G system — the first insulin pump system in Canada that helps to stabilize glucose levels 24 hours a day by automatically adjusting basal insulin delivery based on real-time insulin needs.

  3. Critical Cleaning Detergents Supplier Alconox To Exhibit At Pack Expo Conference 2018

    Visit Alconox, Inc. at PACK EXPO International and Healthcare Packaging EXPO 2018, at McCormick Place in Chicago, October 14-17, 2018. Mention Code: 72W43 for free registration to the event.

  4. FDA Approves Bose’s User-Controlled, Self-Fitting Hearing Aid

    The U.S. Food and Drug Administration today allowed marketing of a new device, the Bose Hearing Aid, intended to amplify sounds for individuals 18 years or older with perceived mild to moderate hearing impairment (hearing loss).

  5. Bristol Instruments Increases The Measurement Range Of Its Optical Thickness Gauge With Addition Of New Model 137LS

    Bristol Instruments, Inc., a leader in optical interferometer-based instrumentation, has expanded its family of non-contact thickness gauges with the addition of the model 137LS Optical Thickness Gauge. This latest system has the capability to measure the thickness of materials up to 28 mm. Expanding the measurement capability of the 137 Optical Thickness Gauge will benefit engineers involved in the development and production of thicker products, such as medical tubing and multi-element optical lens systems.

  6. RAPS Releases Regulatory Professional Compensation Survey Results

    RAPS recently released the results of its comprehensive global survey of healthcare product regulatory professionals, offering a detailed look at how much they earn, which products they work on, what their work entails, and how their roles within their organizations have evolved.

  7. MKS Announces Ophir® LP2 Power/Energy Sensor With Very High Damage Threshold For High Power Density And Long Pulse Lasers

    MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, has announced the L50(150)A-LP2-35, the newest addition to the Ophir® line of LP2 laser power/energy sensors with high damage threshold. The L50(150)A-LP2-35 is a compact, thermal measurement sensor for use with high power density and long pulse lasers. It features an LP2 coating that provides the highest damage threshold in the industry, 33kW/cm2 at full CW power of 150W power. The coating also reduces reflection, absorbing 95% at most wavelengths, and is spectrally flat at ±1% from 0.25µm to 2.2µm.

  8. J&J Completes $2.1B Sale Of Its Blood Glucose Monitoring Business, LifeScan, To Platinum Equity

    Johnson & Johnson recently announced that it has completed the divestiture of its LifeScan business to Platinum Equity for approximately $2.1B.

  9. Label / Graphics Inspection Software Manufacturer Introduces 1st Version Of QC Applications On Macs And PC's

    For the first time, Mac users get access to every GlobalVision inspection module in a single platform. The latest release for desktops, GlobalVision 5.2.2, marks the first version of the leading-quality control application to be available on both Macs and PCs and feature Text and Spelling Inspection modes on top of Graphics, Barcode, and Braille.

  10. FDA Approves Boston Scientific’s Drug-Eluting Vascular Stent System

    Today, Boston Scientific (NYSE: BSX) announced that the U.S. Food and Drug Administration (FDA) has approved its Premarket Approval (PMA) application to market the Eluvia™ Drug-Eluting Vascular Stent System, specifically developed for the treatment of peripheral artery disease (PAD).